Status:

NOT_YET_RECRUITING

Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

Direct MS Canada

Conditions:

Multiple Sclerosis

Mobility Limitation

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This study will evaluate the effects of combining balance training with electrical stimulation techniques in individuals with Multiple Sclerosis (MS). MS commonly impairs leg strength, coordination, a...

Eligibility Criteria

Inclusion

  • Participants will be eligible if they meet the following conditions:
  • Confirmed diagnosis of Multiple Sclerosis (MS) according to the revised McDonald criteria
  • Age ≤ 65 years
  • Ability to walk at least 100 meters, with or without an assistive device, and without requiring rest
  • Self-reported perception of impaired balance during standing or walking in daily activities
  • Exclusion Criteria:
  • Participants will be excluded if they present with any of the following:
  • Uncorrected visual problems
  • Cognitive impairment affecting comprehension of instructions or completion of self-administered outcome measures
  • Ongoing MS exacerbation or paroxysmal vertigo
  • Concurrent neurological or orthopedic conditions affecting balance
  • Recent participation in rehabilitation therapies (physical therapy, occupational therapy, or vestibular therapy) within one month prior to recruitment
  • Planned or recent injection of botulinum toxin to the legs during the intervention period
  • Peripheral nerve damage affecting the legs
  • Contraindications to electrical stimulation, including:implanted electronic device, active cancer or radiation treatment within the past 6 months, uncontrolled epilepsy, skin rash or open wound at electrode site, pregnancy, active deep vein thrombosis

Exclusion

    Key Trial Info

    Start Date :

    October 30 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 30 2028

    Estimated Enrollment :

    24 Patients enrolled

    Trial Details

    Trial ID

    NCT07174973

    Start Date

    October 30 2025

    End Date

    December 30 2028

    Last Update

    September 16 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Toronto Rehabilitation Institute

    Toronto, Ontario, Canada